LiveStay informed about what's happening at Nova
#drugR&D #insilicomedicine #systemsbiology #biomodeling #machinelearning
September 5-7, 2018
Evgueni Jacob, biostatistician at Novadiscovery, will give an oral presentation on “An in silico HBV model predicts viral response to the oral non-steroidal carboxylic acid FXR agonist EYP001a” at the VPH conference 2018, Saragoza, Spain.
September 4, 2018, 15.00-17.00
European Parliament, Brussels, Belgium
In vivo, in vitro, in silico: Why computer modelling is the next evolution of the healthcare sector.
The collective work of Avicenna members, including Novadiscovery, will be showcased.